skip to main content
Refinado por: tipo de recurso: Newsletter Articles remover xxx: xxx remover
Result Number Material Type Add to My Shelf Action Record Details and Options
1
The University of Manitoba; Researchers Submit Patent Application, "Methods to Produce Single Glycoform Antibodies", for Approval (USPTO 20170051328)
Material Type:
Newsletter Articles
Adicionar ao Meu Espaço

The University of Manitoba; Researchers Submit Patent Application, "Methods to Produce Single Glycoform Antibodies", for Approval (USPTO 20170051328)

Biotech Week, 2017, p.1145

Atlanta: NewsRx

Texto completo disponível

2
Findings from Fudan University Shanghai Cancer Center Provide New Insights into Prostate Cancer (Prostate Cancer Screening Using Prostate-Specific Antigen Tests in a High-Risk Population in China: A Cost-Utility Analysis)
Material Type:
Newsletter Articles
Adicionar ao Meu Espaço

Findings from Fudan University Shanghai Cancer Center Provide New Insights into Prostate Cancer (Prostate Cancer Screening Using Prostate-Specific Antigen Tests in a High-Risk Population in China: A Cost-Utility Analysis)

Health & Medicine Week, 2021

NewsRX LLC

Texto completo disponível

3
"Glypican-2-Binding Moieties, Chimeric Antigen Receptors And Uses Thereof" in Patent Application Approval Process
Material Type:
Newsletter Articles
Adicionar ao Meu Espaço

"Glypican-2-Binding Moieties, Chimeric Antigen Receptors And Uses Thereof" in Patent Application Approval Process

Pain & Central Nervous System Week, 2023, p.217

NewsRX LLC

Texto completo disponível

4
Patent Application Titled "Fusion Proteins For Selectively Depleting Antigen-Specific Antibodies" Published Online
Material Type:
Newsletter Articles
Adicionar ao Meu Espaço

Patent Application Titled "Fusion Proteins For Selectively Depleting Antigen-Specific Antibodies" Published Online

Nanotechnology Weekly, 2023, p.565

NewsRX LLC

Texto completo disponível

5
Ocugen Inc.; "Ophthalmic Compositions And Methods Of Use" in Patent Application Approval Process (USPTO 20190008920)
Material Type:
Newsletter Articles
Adicionar ao Meu Espaço

Ocugen Inc.; "Ophthalmic Compositions And Methods Of Use" in Patent Application Approval Process (USPTO 20190008920)

Genomics & Genetics Weekly, 2019, p.353

Atlanta: NewsRx

Texto completo disponível

6
Peptides and Proteins - Amyloid; Findings from Institute of Biochemistry and Biophysics Provide New Insights into Amyloid [Oligopeptides Generated by Neprilysin Degradation of b-Amyloid Have the Highest Cu(II) Affinity in the Whole Ab Family]
Material Type:
Newsletter Articles
Adicionar ao Meu Espaço
7
Peptides and Proteins - Amyloid; Researchers from University of Melbourne Report New Studies and Findings in the Area of Amyloid [Oligopeptides Generated by Neprilysin Degradation of beta-Amyloid Have the Highest Cu(II) Affinity in the Whole A beta Family]
Material Type:
Newsletter Articles
Adicionar ao Meu Espaço
8
University of Southampton; "Human Immune Therapies Using A Cd27 Agonist In Combination With Another Immune Agonist To Treat Cancer" in Patent Application Approval Process (USPTO 20180273631)
Material Type:
Newsletter Articles
Adicionar ao Meu Espaço

University of Southampton; "Human Immune Therapies Using A Cd27 Agonist In Combination With Another Immune Agonist To Treat Cancer" in Patent Application Approval Process (USPTO 20180273631)

Biotech Business Week, 2018, p.217

Atlanta: NewsRx

Texto completo disponível

9
Patents; "Method for Detecting Or Monitoring Prostate Cancer" in Patent Application Approval Process
Material Type:
Newsletter Articles
Adicionar ao Meu Espaço

Patents; "Method for Detecting Or Monitoring Prostate Cancer" in Patent Application Approval Process

Nanotechnology Weekly, 2015, p.604

Atlanta: NewsRx

Texto completo disponível

Personalize Seus Resultados

  1. Editar

Refine Search Results

Expandir Meus Resultados

  1.   

Data de Publicação 

De até
  1. Antes de2015  (1)
  2. 2015Até2016  (1)
  3. 2017Até2017  (1)
  4. 2018Até2019  (4)
  5. Após 2019  (3)
  6. Mais opções open sub menu

Buscando em bases de dados remotas. Favor aguardar.